Arkolith/Insider Trading/DSGN/Form 4

William Arsani

DirectorDesign Therapeutics, Inc. (DSGN) · full profile →Form 4 · filed Aug 30, 2023
Net Buying
Open-Market Buys
$5.4M
Open-Market Sells
$0
Net Open-Market Flow
$5.4M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 29, 2023Buy(P)2.0M$2.44$4.8M3.0M
Aug 28, 2023Buy(P)275K$2.15$591K1.0M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-047773) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML